Suppr超能文献

CT扫描时代治疗的低级别纯性和混合性脑星形细胞瘤

Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era.

作者信息

Bahary J P, Villemure J G, Choi S, Leblanc R, Olivier A, Bertrand G, Souhami L, Tampieri D, Hazel J

机构信息

Department of Oncology (Division of Radiation Oncology), McGill University, Montreal, Canada.

出版信息

J Neurooncol. 1996 Feb;27(2):173-7. doi: 10.1007/BF00177481.

Abstract

From 1974 to 1992, 63 patients diagnosed with low-grade pure or mixed oligo-astrocytoma were seen and treated at our institution. All patients underwent CT scan pre-operatively. There were 20 female and 43 males ranging in age from 12 to 73 years (median age of 33 years). 15 patients had a stereotactic biopsy as the only surgical procedure. 34 had a partial tumor resection and 14 a gross total tumor resection. 43 patients were treated with post-operative radiotherapy whereas 20 patients underwent surgery only as part of the initial management. 50 to 60 Gy (median 59.4 Gy) were given with daily fractions of 1.8 to 2 GY. Tumor volume ranged from 3.4 to 441 cm3. Median tumor volume was larger for radiotherapy treated patients. Median follow-up was 54 months (range of 4 to 240 months). The overall 10 and 15 actuarial survival rates were 37% and 25% respectively. The 5 years survival rate for patients treated at initial diagnosis with surgery alone was 66% and it was 67.3% for patients treated with radiation therapy (P = NS). Prognostic factors having independent significant impact on survival were: extent of surgery, age gender and tumor volume. As well, survival for patients with low-grade astrocytoma in the CT scan era appears to be improved compared to historical controls in the literature.

摘要

1974年至1992年期间,我院共诊治了63例诊断为低级别纯少突胶质细胞瘤或混合性少突星形细胞瘤的患者。所有患者术前均接受了CT扫描。其中女性20例,男性43例,年龄在12岁至73岁之间(中位年龄33岁)。15例患者仅接受了立体定向活检作为唯一的手术操作。34例患者进行了肿瘤部分切除术,14例患者进行了肿瘤全切除术。43例患者术后接受了放疗,而20例患者仅将手术作为初始治疗的一部分。放疗剂量为50至60 Gy(中位剂量59.4 Gy),每日分次剂量为1.8至2 Gy。肿瘤体积范围为3.4至441 cm³。接受放疗患者的肿瘤体积中位数更大。中位随访时间为54个月(范围为4至240个月)。总体10年和15年实际生存率分别为37%和25%。初诊时仅接受手术治疗的患者5年生存率为66%,接受放疗患者的5年生存率为67.3%(P = 无统计学意义)。对生存有独立显著影响的预后因素包括:手术范围、年龄、性别和肿瘤体积。此外,与文献中的历史对照相比,CT扫描时代低级别星形细胞瘤患者的生存率似乎有所提高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验